Literature DB >> 6407511

Change of pyruvate kinase isozymes from M2- to L-type during development of the red cell.

S Takegawa, H Fujii, S Miwa.   

Abstract

The relationship between erythroid cell maturation and the change of pyruvate kinase (PK) isozymes was studied using fluorescent antibody techniques. The fluorescence of M2-type PK was strongest in the proerythroblast stage, and then steeply declined with red cell maturation so that only weak fluorescence was seen in orthochromatic erythroblasts. On the other hand, the fluorescence of L-type PK was seen throughout the maturation of the erythroblasts, with stronger fluorescence in the basophilic or polychromatic erythroblasts than in proerythroblasts.

Mesh:

Substances:

Year:  1983        PMID: 6407511     DOI: 10.1111/j.1365-2141.1983.tb02121.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Alternative splicing of human glucose-6-phosphate dehydrogenase messenger RNA in different tissues.

Authors:  A Hirono; E Beutler
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Pyruvate kinase and the "high ATP syndrome".

Authors:  G E Staal; G Jansen; D Roos
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

Review 3.  Role of Pyruvate Kinase M2 (PKM2) in Cardiovascular Diseases.

Authors:  Mohd Rihan; Shyam Sunder Sharma
Journal:  J Cardiovasc Transl Res       Date:  2022-09-30       Impact factor: 3.216

4.  Rabbit bone marrow glucose-6-phosphate dehydrogenase during erythroid cell development.

Authors:  P Ninfali; F Palma; G Fornaini
Journal:  Mol Cell Biochem       Date:  1987-06       Impact factor: 3.396

5.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

6.  Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.

Authors:  Grant D Trobridge; Brian C Beard; Robert A Wu; Christina Ironside; Punam Malik; Hans-Peter Kiem
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Apoptotic changes precede mitochondrial dysfunction in red cell-type pyruvate kinase mutant mouse erythroleukemia cell lines.

Authors:  K Aisaki; H Kanno; N Oyaizu; Y Hara; S Miwa; Y Ikawa
Journal:  Jpn J Cancer Res       Date:  1999-02

Review 8.  FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.

Authors:  Emmanouil Simantirakis; Ioannis Tsironis; George Vassilopoulos
Journal:  Viruses       Date:  2020-03-19       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.